San Francisco - The FDA has its eye on New-Fill (Dermik Laboratories), a polylactic acid filler that experts predict could become a popular treatment for moderate to deep wrinkles and volume loss.
Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Facial Skin Cancer Surgery Yields Low and Improved Scores For Perceived Stigmatization, Body Image Concerns, and Psychosocial Distress
ReV Up Your Vitiligo Treatment Strategies
Ruxolitinib, Educational Initiatives for Managed Care Professionals Play Crucial Role in Optimizing Care in Atopic Dermatitis
ASLAN Announces Positive Phase 2 Results of Eblasakimab in Dupilumab-Treated Patients With AD